PharmaSUG2025paper·US·Statistics and Analytics
Practical considerations for Intercurrent Events and Multiple Imputation SA-245
Official-source directory
Conference Papers
13,885
available papers
10
available conferences
Papers
Showing 1981–2000 of 13,885
PharmaSUG2025paper·US·Statistics and Analytics
Handling Missing Data in External Control Arms: Best Practices, Recommendations, and SAS Code Examples SA-267
PharmaSUG2025paper·US·Statistics and Analytics
Simulating Optimal Sample Sizes for Canine Jaws Using SAS® SA-270
PharmaSUG2025paper·US·Statistics and Analytics
Roadmap to Efficacy Analysis for Early Phase Oncology studies SA-287
PharmaSUG2025paper·US·Statistics and Analytics
Efficacy Endpoints Related to CNS in Oncology Studies within ADaM SA-321
PharmaSUG2025paper·US·Statistics and Analytics
Implementation of the inverse probability of censoring weighting (IPCW) Model in Oncology Trials SA-343
PharmaSUG2025paper·US·Statistics and Analytics
Incorporating Frailty into Time-to-Event Analysis: A Practical Approach with R frailtypack SA-368
PharmaSUG2025paper·US·Statistics and Analytics
Landmark Analysis: A Method for Accurate Prediction of Time-Dependent Clinical Risks and Their Effect on Patient Outcomes SA-372
PharmaSUG2025paper·China·Statistics and Analytics (SA)
Implementing Multiple Imputation and ANCOVA with Rubin's Rule in R: A Comparative Study with SAS SA-105 Shanghai
PharmaSUG2025paper·China·Statistics and Analytics (SA)
Statistical Methods and Programming Practice of Study-size Adjusted Risk Difference in Safety Pooling SA-110 Shanghai
PharmaSUG2025paper·China·Statistics and Analytics (SA)
Using VBA to Calculate Statistical Indicators for Consistency Evaluation in Clinical Trials of Diagnostic Assays SA-118 Shanghai
PharmaSUG2025paper·China·Statistics and Analytics (SA)
Propensity Score Weighting in a two-arm observational study with binary outcome SA-121 Shanghai
PharmaSUG2025paper·China·Statistics and Analytics (SA)
Companion Diagnostics and Regulatory Strategies: Insights from the INNOVANCE Antithrombin Assay SA-127 Shanghai
PharmaSUG2025paper·China·Statistics and Analytics (SA)
Handling Missing Data in Clinical Trials with Multiple Imputation Methods SA-148 Shanghai
PharmaSUG2025paper·China·Statistics and Analytics (SA)
Ensure the statistical validity in the context of open-source under GxP Compliant Environment SA-153 Shanghai
PharmaSUG2025paper·China·Statistics and Analytics (SA)
Data Analysis in Pediatric Clinical Trials SA-174 Shanghai
PharmaSUG2025paper·China·Statistics and Analytics (SA)
A Navigation to the Drug-Drug Interaction (DDI) Study: Implementation Frameworks, Carry-over Effects and Advanced Statistical Approaches SA-186 Shanghai
PharmaSUG2025paper·US·Strategic Implementation & Innovation
The Current State of Teaching Biostatistics in Academia: Challenges and Software Solutions SI-046
PharmaSUG2025paper·US·Strategic Implementation & Innovation
Generative AI in Biometrics: Transforming Clinical Trials with Supercharged Efficiency an Innovation SI-061
PharmaSUG2025paper·US·Strategic Implementation & Innovation
Strategies to Encourage Adoption and Innovation in Statistical Programming SI-064